Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-23-036040

Chief Financial Officer bought 20,000 shares at $2.06 ($41,286)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Byam Rebecca Chief Financial Officer 2023-06-09 Purchase +20,000 $2.06 $41,286 543,946 D
Open-market purchases · 20,000 sh · avg $2.06 · $41,286
Loading xslF345X04/doc4.xml…